NASA will test SpinLaunch’s ability to fling satellites into orbit

NASA has signed up to test SpinLaunch's extraordinary whirl 'n' hurl space launch technology, which accelerates a launch vehicle to hypersonic speeds using an electric centrifuge arm instead of a rocket, hurling it skyward like a space discus.

Source of Article

Continue ReadingNASA will test SpinLaunch’s ability to fling satellites into orbit

New hypothesis argues leaky blood-brain barrier triggers Alzheimer’s

A new article has proposed a novel hypothesis for the cause of Alzheimer’s, arguing the disease is caused by a damaged blood-brain barrier allowing fatty molecules to invade the brain and trigger a cascade of events resulting in cognitive decline.

Source of Article

Continue ReadingNew hypothesis argues leaky blood-brain barrier triggers Alzheimer’s

Implantable film fires up nearby nerve cells when triggered with light

By taking ultrathin films and color pigments used routinely in the food industry, scientists have developed an implantable device that can be activated by light to stimulate nerve cells and accelerate healing.

Source of Article

Continue ReadingImplantable film fires up nearby nerve cells when triggered with light

DHC-515 firefighting seaplane reloads from bodies of water in 12 seconds

De Havilland Canada has introduced its latest seaplane for battling forest and wildfires, the DHC-515 Firefighter. The new plane features a number of upgrades, including the ability to take on a full load of fresh or saltwater in 12 seconds.

Source of Article

Continue ReadingDHC-515 firefighting seaplane reloads from bodies of water in 12 seconds

mRNA vaccine boosts cancer immunotherapy in early human trial data

Preliminary data has provided promising signs for a new cancer treatment that combines immunotherapy with an mRNA vaccine. First reports from the Phase 1 human trial indicate the treatment is safe and potentially effective against solid tumors.

Source of Article

Continue ReadingmRNA vaccine boosts cancer immunotherapy in early human trial data